Restasis 2003 fda?

What is Restasis, and what did the FDA approve in 2003?

Restasis is the brand name for cyclosporine ophthalmic emulsion, used for dry eye disease. It was FDA-approved in 2003 as a prescription eye drop to help increase tear production in patients with chronic dry eye disease. [1]

Why was Restasis approved by the FDA?

The FDA approval was tied to the drug’s role in treating dry eye by targeting inflammation associated with the condition, aiming to improve tear production and symptoms in appropriate patients. [1]

What happens if you search “Restasis 2003 FDA”?

Most searchers are looking for one of these details:
- the approval year (2003) [1]
- the active ingredient (cyclosporine) [1]
- the indication (dry eye treatment to improve tear production) [1]

If you meant a specific document (for example, the original FDA approval letter, the drug label, or an FDA database entry), tell me what you’re trying to find and I can narrow it down.

Where to verify Restasis’s FDA approval info

You can cross-check drug history and related patent/exclusivity research on DrugPatentWatch: [2]

Sources:
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
[2] https://www.drugpatentwatch.com/